Cargando…
Inclisiran—A Revolutionary Addition to a Cholesterol-Lowering Therapy
Hypercholesterolemia plays a crucial role in the development of atherosclerosis, but it remains an undertreated and underdiagnosed disease. Taking into consideration the high prevalence of lipid disorders, long duration of the asymptomatic course of the disease, life-threatening complications result...
Autores principales: | Dec, Adrianna, Niemiec, Aleksandra, Wojciechowska, Eliza, Maligłówka, Mateusz, Bułdak, Łukasz, Bołdys, Aleksandra, Okopień, Bogusław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095256/ https://www.ncbi.nlm.nih.gov/pubmed/37047830 http://dx.doi.org/10.3390/ijms24076858 |
Ejemplares similares
-
Potential Therapeutic Strategies in the Treatment of Metabolic-Associated Fatty Liver Disease
por: Bołdys, Aleksandra, et al.
Publicado: (2023) -
Insight into the Evolving Role of PCSK9
por: Maligłówka, Mateusz, et al.
Publicado: (2022) -
Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages
por: Bułdak, Łukasz, et al.
Publicado: (2015) -
Metformin reduces the expression of NADPH oxidase and increases the expression of antioxidative enzymes in human monocytes/macrophages cultured in vitro
por: Bułdak, Łukasz, et al.
Publicado: (2017) -
Pleiotropic Effects of PCSK-9 Inhibitors
por: Basiak, Marcin, et al.
Publicado: (2021)